Complications of Percutaneous Thermal Ablation of Primary and Metastatic Lung Tumors: Review of Prevention and Management Strategies
- 1Department of Diagnostic Radiology, Tan Tock Seng Hospital, Singapore 308433, Singapore
Abstract
Pulmonary malignancies encompassing both primary lung cancer and metastatic lesions are a leading cause of cancer-related mortality globally. Percutaneous thermal ablation of primary and metastatic lung tumors using radiofrequency ablation, microwave ablation, or cryoablation has emerged as an established minimally invasive treatment modality for selected patients unsuitable for surgery or requiring lung preservation. Although most lung ablation complications are self-limiting, some adverse events may result in long-term morbidity or mortality. Post-ablation pneumothorax has the highest reported incidence, with pooled incidences of 37–44%, although rates may vary according to patient cohorts and study definitions. As indications for percutaneous thermal ablation of pulmonary lesions expand to include complex lesions or higher-risk patients, the prevention and management of procedure-related complications remain central to safe clinical practice. Although prior reviews have described the techniques, oncological outcomes, and complication profiles of image-guided lung ablation, less emphasis has been placed on integrating practical complication prevention and management strategies throughout the periprocedural workflow. This narrative review aims to synthesize various complication prevention and management strategies for percutaneous thermal ablation of both primary and metastatic pulmonary lesions. The review focuses on both common and rare complications, and various aspects of complication prevention such as patient/lesion selection, procedural planning, and anesthesia/respiratory control. A comprehensive understanding of complication profiles and mitigation strategies is essential to optimize procedural safety, guide patient selection, and establish ablative techniques as a pillar in multidisciplinary thoracic oncology care.
Related
- Urinary Complications and Injuries Related to Vaginal Mesh Surgery for Pelvic Organ Prolapse: Prevention and Management
- Thrombotic Complications in Women Undergoing Assisted Reproductive Technologies: Pathophysiology, Prevention, and Clinical Management—A Narrative Review
- Prevention and management of bleeding complications in interventional ultrasound: an international expert consensus statement
- Clinically Actionable Prevention and Management of Major Complications During Durable Left Ventricular Assist Device Support: A Contemporary Narrative Review
- A proposal for the classification of early complications during percutaneous central venous access: previous note
BibTeX
@article{how2026complications,
title = {{Complications of Percutaneous Thermal Ablation of Primary and Metastatic Lung Tumors: Review of Prevention and Management Strategies}},
author = {Guo Yuan How and Uei Pua},
journal = {Cancers},
year = {2026},
month = oct,
doi = {10.3390/cancers18203284},
url = {https://www.mdpi.com/2072-6694/18/20/3284},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Complications of Percutaneous Thermal Ablation of Primary and Metastatic Lung Tumors: Review of Prevention and Management Strategies
AU - Guo Yuan How
AU - Uei Pua
PY - 2026
DA - 2026/10/12
JO - Cancers
DO - 10.3390/cancers18203284
UR - https://www.mdpi.com/2072-6694/18/20/3284
AB - Pulmonary malignancies encompassing both primary lung cancer and metastatic lesions are a leading cause of cancer-related mortality globally. Percutaneous thermal ablation of primary and metastatic lung tumors using radiofrequency ablation, microwave ablation, or cryoablation has emerged as an established minimally invasive treatment modality for selected patients unsuitable for surgery or requiring lung preservation. Although most lung ablation complications are self-limiting, some adverse events may result in long-term morbidity or mortality. Post-ablation pneumothorax has the highest reported incidence, with pooled incidences of 37–44%, although rates may vary according to patient cohorts and study definitions. As indications for percutaneous thermal ablation of pulmonary lesions expand to include complex lesions or higher-risk patients, the prevention and management of procedure-related complications remain central to safe clinical practice. Although prior reviews have described the techniques, oncological outcomes, and complication profiles of image-guided lung ablation, less emphasis has been placed on integrating practical complication prevention and management strategies throughout the periprocedural workflow. This narrative review aims to synthesize various complication prevention and management strategies for percutaneous thermal ablation of both primary and metastatic pulmonary lesions. The review focuses on both common and rare complications, and various aspects of complication prevention such as patient/lesion selection, procedural planning, and anesthesia/respiratory control. A comprehensive understanding of complication profiles and mitigation strategies is essential to optimize procedural safety, guide patient selection, and establish ablative techniques as a pillar in multidisciplinary thoracic oncology care.
SN - 2072-6694
ER -